Gain-of-function missense RARβ variants found in AM patients were shown to exhibit increased response to retinoic acid ligands compared to the wild-type, indicating an increase in retinoic acid signalling mediated by RARβ is sufficient to disrupt eye development [87,88]. This evidence concerns the gene RARB and acute myeloblastic leukemia with maturation.